Portal de Periódicos da CAPES

Successful treatment of fluoxetine‐indueed dystonia with low‐dose mianserin

1997; Wiley; Volume: 12; Issue: 6 Linguagem: Inglês

10.1002/mds.870120650

1531-8257

Michael Poyurovsky, Michael Schneidman, Abraham Weizman,

Genetic Neurodegenerative Diseases

Movement DisordersVolume 12, Issue 6 p. 1102-1105 Clinical/Scientific Note Successful treatment of fluoxetine-indueed dystonia with low-dose mianserin Dr. Michael Poyurovsky, Corresponding Author Dr. Michael Poyurovsky Tirat Carmel Mental Health Center Tirat Carmel Beilinson Campus Petah Tikva, IsraelTirat Carmel Mental Health Center, P.O. Box 9, Tirat Carmel 30200, IsraelSearch for more papers by this authorMichael Schneidman, Michael Schneidman Tirat Carmel Mental Health Center Tirat Carmel Beilinson Campus Petah Tikva, IsraelSearch for more papers by this authorAbraham Weizman, Abraham Weizman Felsenstein Medical Research Center and Geha Psychiatric Hospital Rabin Medical Center Beilinson Campus Petah Tikva, IsraelSearch for more papers by this author Dr. Michael Poyurovsky, Corresponding Author Dr. Michael Poyurovsky Tirat Carmel Mental Health Center Tirat Carmel Beilinson Campus Petah Tikva, IsraelTirat Carmel Mental Health Center, P.O. Box 9, Tirat Carmel 30200, IsraelSearch for more papers by this authorMichael Schneidman, Michael Schneidman Tirat Carmel Mental Health Center Tirat Carmel Beilinson Campus Petah Tikva, IsraelSearch for more papers by this authorAbraham Weizman, Abraham Weizman Felsenstein Medical Research Center and Geha Psychiatric Hospital Rabin Medical Center Beilinson Campus Petah Tikva, IsraelSearch for more papers by this author First published: 04 November 2004 https://doi.org/10.1002/mds.870120650Citations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 1994; 165: 728–733. 2 Lipinski JF, Mallya G, Zimmerman P, et al. Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry 1989: 50: 339–342. 3 Fallen BA, Liebowitz MR. Fluoxetine and extrapyramidal symptoms in CNS lupus. J Clin Psychopharmacol 1991; 11: 147–148. 4 Coulter DM, Pillans PI. Fluoxetine and extrapyramidal side effects. Am J Psychiatry 1995; 152: 122–125. 5 Casey DE. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models. Br J Psychiatry 1996; 168 (suppl 29): 32–39. 6 Meltzer HY, Young GM, Metz J, Fand VS, Schyve PM, Arora RC. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm 1979; 45: 165–175. 7 Reccoppa L, Welch WA, Ware MR. Acute dystonia and fluoxetine [letter]. J Clin Psychiatry 1990; 51: 487. 8 Black B, Uhde TW. Acute dystonia and fluoxetine [letter], J Clin Psychiatry 1992; 53: 327. 9 Dave M. Fluoxetine-associated dystonia. Am J Psychiatry 1994; 151: 149. 10 Miller CH, Fleishhacker WW, Ehrman H, Kane JM. Treatment of Neuroleptic-induced akathisia with the 5-HT antagonist ritanserin. Psychopharmacol Bull 1990; 26: 373–376. 11 Weiss D, Aizenberg D, Hermesh D, et al. Cyproheptadine treatment in Neuroleptic-induced akathisia. Br J Psychiatry 1995; 166: 352–357. 12 Maj J, Sowinska H, Baran L, Gancarcyk L, Rawlow A. The central antiserotonergic action of mianserin. Psychopharmacology 1978; 59: 79–84. 13 Poyurovsky M, Meerovich I, Weizman A. Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient. Int Clin Psychopharmacol 1995; 10: 111–115. 14 Poyurovsky M, Kreinin A, Modai I, Weizman A. Lithium-induced akathisia responds to low-dose mianserin: case report. Int Clin Psychopharmacol 1995; 10: 261–263. 15 Poyurovsky M, Kosov A, Halperin E, Enoch D, Schneidman M, Weizman A. Akathisia-like behavior following ECT and its successful treatment with low-dose mianserin. Int Clin Psychopharmacol 1995; 10: 257–260. 16 Waldmeier PC, Delini-Stula AA. Serotonin-dopamine interactions in the nigrostriatal system. Eur J Pharmacol 1979; 55: 363–373. 17 Korsgaard S, Gerlach H, Christensson E. Behavioral aspects of serotonin-dopamine interactions in monkeys. Abstracts of the 13th C.N.I.P. Congress 1986, Jerusalem, 400. 18 Leo RG. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996; 57: 449–454. 19 Zubenko GC, Cohen BM, Lipinski JF Jr. Antidepressant-related akathisia. J Clin Psychopharmacol 1987; 7: 254–257. 20 Poyurovsky M, Fuchs C, Weizman A. Low-dose mianserin in neuroleptic induced akathisia. Br J Psychiatry (in press; 1997). 21 Povlsen UJ, Noring U, Laurse AML, Korsgaard S, Gerlach J. Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeys. Clin Neuropharmacol 1986; 9: 84–90. 22 Korsgaard S, Friis T. Effects of mianserin in Neuroleptic-induced parkinsonism. Psychopharmacology 1978; 59: 79–84. Citing Literature Volume12, Issue6November 1997Pages 1102-1105 ReferencesRelatedInformation